LUCID DIAGNOSTICS INC.

Analyst Reco. Lucid Diagnostics Inc.

Equities

LUCD

US54948X1090

Market Closed - Nasdaq Other stock markets 21:00:00 28/06/2024 BST			5-day change	1st Jan Change
0.82 ^USD	-5.64%		+18.34%	-41.84%

05-13	Transcript : Lucid Diagnostics Inc., Q1 2024 Earnings Call, May 13, 2024
05-13	Lucid Diagnostics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cantor Fitzgerald Trims Price Target on Lucid Diagnostics to $3 From $3.80, Maintains Overweight Rating	03-27	MT
Needham Adjusts Price Target on Lucid Diagnostics to $2.80 From $2.60, Maintains Buy Rating	17/05/23	MT
BTIG Adjusts Lucid Diagnostics' Price Target to $3.50 From $5, Keeps Buy Rating	18/11/22	MT
Needham Adjusts Price Target on Lucid Diagnostics to $3.10 From $4.25, Maintains Buy Rating	15/11/22	MT
Needham Cuts Price Target on Lucid Diagnostics to $4.25 From $5, 2023 Revenue Estimate to $15 Million From $20.8 Million; Buy Rating Kept	16/08/22	MT
Needham Adjusts Lucid Diagnostics' Price Target to $5 From $7 on 'Peer Multiple Compression,' Reiterates Buy Rating	12/05/22	MT
Canaccord Genuity Adjusts Lucid Diagnostics' Price Target to $12 From $18, Reiterates Buy Rating	29/03/22	MT
Needham Adjusts Lucid Diagnostics' Price Target to $7 From $13, Citing Peer Multiple Compression, Lowered Revenue Expectation; Buy Rating Kept	29/03/22	MT
Ascendiant Capital Starts Lucid Diagnostics at Buy With $16 Price Target	27/12/21	MT
Needham Lowers Lucid Diagnostics' Price Target to $13 From $17, Citing 'Peer Multiple Contraction;' Buy Rating Kept	15/12/21	MT
Canaccord Genuity Initiates Lucid Diagnostics at Buy Rating With $18 Price Target	08/11/21	MT
BTIG Starts Lucid Diagnostics at Buy with $14 Price Target	08/11/21	MT
Cantor Fitzgerald Starts Lucid Diagnostics at Overweight With $21 Price Target	08/11/21	MT
Needham Starts Lucid Diagnostics at Buy With $17 Price Target	08/11/21	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Our Free Content Help you Secure and Increase the Performance of Your Investments

Securing my Investments

fermer